The Interdisciplinary Management and Safety Perspectives in Endocrine, Metabolic and Psychiatric Disorder

Endocr Metab Immune Disord Drug Targets. 2022;22(13):1233-1234. doi: 10.2174/187153032213221021164256.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Mental Disorders* / diagnosis
  • Mental Disorders* / epidemiology
  • Mental Disorders* / therapy